Leonardo Jaimes, MD

All articles by Leonardo Jaimes, MD

• CD30 inhibitor could improve cutaneous mastocytosis, study suggests

  The cellular marker CD30 appears to play a key role in cutaneous mastocytosis, which differs from systemic mastocytosis, a new study says.

• Patients with MCAS may have increased risk of systemic mastocytosis

  Patients with mast cell activation syndrome (MCAS) could require annual controls to detect potential progression to systemic mastocytosis.

• Case report: Patient with SM responds to experimental treatment

  A new case study reported promising results for a man who started experimental therapy for SM symptoms after other treatment failed.

• Market for SM treatments to rise significantly through 2034, new study says

  Increased awareness and diagnosis of SM could increase the growth of the SM pharmaceutical market by 2034.

• Perspectives and challenges in advanced SM management

  A recent study assessed the current state of treatments for advanced systemic mastocytosis and the promise of future ones.

• Case report: SM presents as osteoporosis in male patient

  A new study detailed a rare case of a man with systemic mastocytosis who presented with symptoms of osteoporosis.

• Case of mastocytosis may be linked to cancer radiation treatment

  A new case revealed suspected systemic mastocytosis following a female patient’s radiation therapy for breast cancer

• Rare pediatric SM case presents as skull lesion

  Systemic mastocytosis is rare in children, and this case was particularly rare because of its lone symptom.

• Study proposes unifying SM diagnostic criteria

  A recent article proposed unifying the 2001 WHO SM diagnostic criteria and revised criteria of the 2021 International Consensus Classification Group.

• Two prognostic scoring systems best predict advanced SM outcomes

  A recent report shows two specific prognostic scoring systems have the most accurate predictive value for advanced SM outcomes.